Acute Bronchitis Management
Initial Assessment and Diagnosis
- The American College of Physicians recommends ruling out pneumonia by evaluating for tachycardia, tachypnea, fever, and abnormal chest examination findings in patients with suspected acute bronchitis 1
- Acute bronchitis is characterized by cough with or without phlegm production lasting up to 3 weeks, with normal chest radiograph findings, and is caused by respiratory viruses in 89-95% of cases 1
Primary Treatment Approach: Symptomatic Management
- The American Academy of Family Physicians recommends against routine prescription of antibiotics for uncomplicated acute bronchitis, as they provide minimal benefit and contribute to antibiotic resistance 1
- Purulent sputum does not signify bacterial infection and is present in 89-95% of viral cases, according to the American College of Physicians 1
- The American Thoracic Society recommends against routine use of β2-agonist bronchodilators for cough in most patients with acute bronchitis 1
- Expectorants, mucolytics, and antihistamines lack evidence of benefit in treating acute bronchitis, according to the American College of Chest Physicians 2
Symptomatic Treatment Options
- Codeine or dextromethorphan may provide modest effects on severity and duration of cough in patients with acute bronchitis, as recommended by the American Academy of Family Physicians 1
- β2-agonist bronchodilators may be useful in select adult patients with wheezing accompanying the cough, according to the American College of Physicians 1
Exception: Pertussis (Whooping Cough)
- The Centers for Disease Control and Prevention recommend prescribing a macrolide antibiotic, such as erythromycin or azithromycin, for confirmed or suspected pertussis 1
- Patients with pertussis should be isolated for 5 days from the start of treatment, as recommended by the American Academy of Pediatrics 1
High-Risk Patients Requiring Special Consideration
- The American Geriatrics Society recommends considering antibiotics only in high-risk patients with significant comorbidities, such as age ≥75 years with fever, cardiac failure, insulin-dependent diabetes, immunosuppression, or serious neurological disorders 1, 2
- The Infectious Diseases Society of America recommends doxycycline 100 mg twice daily for 7-10 days as a first-line treatment for moderate severity bacterial bronchitis in high-risk patients 1
Patient Education and Communication
- The American Academy of Family Physicians recommends informing patients that cough typically lasts 10-14 days after the office visit, even without antibiotics 1
- Key communication strategies include referring to the condition as a "chest cold" rather than bronchitis, explaining that patient satisfaction depends more on physician-patient communication, and discussing the risks of unnecessary antibiotic use, as recommended by the American College of Physicians 1